
Michael Prados
Orthopaedic Surgery / Hand Surgery
Credentials: · ·
History
Medical Oncology
Internal Medicine
Research
The somatic genomic landscape of glioblastoma
Cell · 2013 · 4,080 citations
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
Journal of Clinical Oncology · 2009 · 2,000 citations
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
New England Journal of Medicine · 2015 · 1,610 citations

149 papers · 37 as a resident

79 papers · 1 as a fellow

60 papers
- PW
58 papers
- WW
42 papers

41 papers
- HR
40 papers

40 papers · 2 as a fellow
Grants
- 2009–2014
Adult Brain Tumor Consortium (ABTC)
National Cancer Institute · U01
PI · $11M · Johns Hopkins University
- 1994–2009
NABTC Central Operation Grant (UCSF Project Leader)
National Cancer Institute · U01
Contact PI · $6.5M · University of California, San Francisco
- 1997–2006
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $2.3M · University of California, San Francisco
- 2004–2005
Pediatric Clinical Research Center
National Center for Research Resources · M01
Project lead · $10.7K · University of California, San Francisco
Clinical trials
- 2014–2017
Principal investigator · Completed
University of California, San Francisco
- 2010–2013
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
Principal investigator · Terminated · Phase 2
University of California, San Francisco
- 2008–2014
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Principal investigator · Completed · Phase 1
University of California, San Francisco
- 2007–2013
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
Principal investigator · Completed · Phase 2
University of California, San Francisco

